Anticipated Shortage

POTASSIUM PHOSPHATES INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of POTASSIUM PHOSPHATES INJECTION, USP in Canada?

A shortage of POTASSIUM PHOSPHATES INJECTION, USP 224MG 236MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 14, 2026), but it has not started yet.

Why is POTASSIUM PHOSPHATES INJECTION, USP not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will POTASSIUM PHOSPHATES INJECTION, USP be available again?

The manufacturer's estimated resolution date is November 13, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusAnticipated Shortage

Same-ingredient products on fileNone found

Expected resolution~2 months remaining (estimate)

Affected strength224MG 236MG

Last updated2026-09-14

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02139545

Strength

224MG 236MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

POTASSIUM PHOSPHATE MONOBASIC POTASSIUM PHOSPHATE DIBASIC

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-09-14

Anticipated Shortage

Disruption of the manufacture of the drug.

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02457482